Navigation Links
First Boston Pharma, LLC Acquires NutraMax Products, Inc.
Date:5/13/2009

GLOUCESTER, Mass., May 13 /PRNewswire/ -- First Boston Pharma announces the acquisition of NutraMax, Products, Inc., a contract manufacturer of solid dose and soft chew pharmaceuticals and supplements. The company will now be known as First Boston Pharma, LLC.

Leading the First Boston Pharma organization is Mario Medri, one of the industry's foremost innovators in over-the-counter ("OTC") drugs and supplement formulations. With over 40 years of experience in the consumer packaging goods industry, Medri has developed a multitude of products in the OTC drug and supplements categories, as well as flavors, fragrances, confections, foods and cosmetics. He holds over 15 product and process patents. Medri's many contributions to the market include inventing soft chews as a vehicle for delivery of OTC drugs and supplements and developing new products and technologies for pectin/menthol cough drops, honey liquid center cough drops and liquid center throat lozenges.

"The acquisition by Mario and the First Boston Pharma Group will propel the company further and faster along the trajectory we are on, particularly with designer products for pharmaceuticals and supplement markets," says Rodney Plunkett, Executive Vice President of First Boston Pharma. "To have the industry's foremost innovator leading First Boston Pharma into the future is an exciting prospect for us and for our customers," adds Plunkett.

The acquisition of NutraMax by First Boston Pharma will provide the necessary resources for the company to pursue its strategy of innovation in the over-the-counter drugs and supplements categories. The company will drive its growth strategy though investment in additional R&D, and in unique production capabilities. "One of our key strategies is to move to a supply base integrity model, which gives our customers the differentiated products they need, when they want them," says Medri.

About First Boston Pharma, LLC:

First Boston Pharma, LLC is a contract manufacturer of solid dose, soft chew, liquid, tablet and chewing gum based pharmaceuticals and supplements servicing branded companies and retailer private label products. The company provides turnkey services to customers wishing to introduce new products from product ideation to R&D, product development to production. Headquartered in Gloucester, MA, First Boston Pharma has an additional facility in Brockton, MA. All facilities are FDA registered drug manufacturing sites, and also cGMP and DSHEA compliant. For more information, visit www.Firstbostonpharma.com

LINKS

Mario Medri mmedri@1stbp.com

Rodney Plunkett rplunkett@1stbp.com

First Boston Pharma, LLC www.firstbostonpharma.com


'/>"/>
SOURCE First Boston Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Super Lice Repelled by All-Natural Products First Ever Independent Study Shows
2. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
3. China Medicine Announces First Quarter 2009 Results
4. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
5. Pharmos Corporation Reports 2009 First Quarter Results
6. Pregis Announces First Quarter 2009 Financial Results
7. Access to care leads Americans priorities in first-ever public study of health value
8. Access to Care Leads Americans Priorities in First-Ever Public Study of Health Value
9. The Nielsen Company Launches First-Ever CLIO Healthcare Awards Acknowledging Creative Excellence in Healthcare Communications
10. Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook
11. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... now offering treatments for sleep apnea and TMJ at their office. TMJ, or ... , specifically the obstructive type, is increasingly being treated at dental offices with ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “End Time GPS”: ... salient events will interrelate. “End Time GPS” is the creation of published author, ... expert while working on military munitions and space-vehicle projects. Now, at age ninety-one, he ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017   ... leading organization within medical affairs in the pharmaceutical ... as the chair of a newly formed scientific ... board members to form the first ever medical ... For more information about the ACMA, please ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
(Date:3/24/2017)... Today Stock-Callers.com have issued research reports ... Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. ... ). These companies are part of the Healthcare sector, which ... 23 rd , 2017, with the NYSE Health Care Index ... companies in the S&P 500 were down about 0.4% as ...
Breaking Medicine Technology: